Description
Rôles et compétences
Rôles et compétences
- Reflections and experiences of early career cancer nurses on cancer survivorship in Europe: A qualitative study.on 16 février 2026
European Journal of Oncology Nursing; 02/01/2026This study explores how early-career cancer nurses across Europe conceptualise and deliver survivorship care, a growing priority in oncology nursing. […]
Formation et apprentissage
- Symptom Management Guideline Implementation Among Nurses in Cancer-Specific Outpatient Settings: A Scoping Review of Barriers, Facilitators, and Implementation Strategies.on 10 Décembre 2025
Cancer Nursing; 01/01/2026Background: Oncology outpatients experience high levels of distressing cancer-related symptoms. Nurses can provide high-quality outpatient cancer symptom management […]
Spécialités cliniques
Oncologie médicale
- Leveraging Artificial Intelligence for Immune Checkpoint Inhibitor Safety: A Scoping Review of Current Applicationson 16 mars 2026
JCO Clin Cancer Inform. 2026 Mar;10:e2500323. doi: 10.1200/CCI-25-00323. Epub 2026 Mar 9.ABSTRACTPURPOSE: To systematically map how artificial intelligence (AI) is being applied to immune-related […]
Chirurgie oncologique
- The AMICO Clinic Approach to Integrative Oncology in Breast Cancer Care: Structure and Clinical Framework From a Southern Italian Hospitalon 16 mars 2026
Integr Cancer Ther. 2026 Jan-Dec;25:15347354251413227. doi: 10.1177/15347354251413227. Epub 2026 Feb 16.ABSTRACTWith increasing survival rates for breast cancer (BC)-91% at 5 years and 80% at 15 […]
Radio-oncologie
- Alternative splicing in cancer drug resistance: Mechanisms and therapeutic prospects (Review)on 5 Décembre 2025
Oncol Rep. 2026 Feb;55(2):31. doi: 10.3892/or.2025.9036. Epub 2025 Dec 5.ABSTRACTAlternative splicing (AS) is one of the principal mechanisms of post‑transcriptional regulation that confers […]
Traitements et interventions
Traitements non-pharmacologiques
- Vitamin/mineral and non-vitamin/non-mineral supplement use of breast cancer survivors in Koreaon 13 avril 2026
Nutr Res Pract. 2026 Apr;20(2):333-345. doi: 10.4162/nrp.2026.20.2.333. Epub 2026 Mar 30.ABSTRACTBACKGROUND/OBJECTIVES: Dietary supplement use is common among breast cancer survivors, but studies on […]
Approches complémentaires
- The effects of aerobic and resistance training across eight cancer types: a systematic reviewon 13 avril 2026
Support Care Cancer. 2026 Jan 31;34(2):149. doi: 10.1007/s00520-026-10363-0.ABSTRACTPURPOSE: Patients with cancer often experience declines in quality of life (QoL), functional capacity, psychosocial […]
Réadaptation, physiothérapie et ergothérapie
- Effects of pulmonary rehabilitation in people with lung cancer after lung resection: a systematic review and meta-analysison 13 avril 2026
J Cancer Surviv. 2026 Jan 30. doi: 10.1007/s11764-025-01952-9. Online ahead of print.ABSTRACTPURPOSE: This systematic review and meta-analysis aims to evaluate the effectiveness of pulmonary […]
Éducation aux patients et littératie en santé
- Cultural and Linguistic Adaptation and Validation of a Nutrition Literacy Instrument for Use in People With Cancer in the United Kingdomon 16 mars 2026
J Hum Nutr Diet. 2026 Apr;39(2):e70218. doi: 10.1111/jhn.70218.ABSTRACTBACKGROUND: Nutrition literacy is a person's ability to gain, retain and use nutrition information to inform healthy lifestyle […]
Organisation des soins
Organisation et unités de soins
- Interventional Oncology Is an Evolving Subspecialty for Oncology Nurses.on 16 février 2026
ONS Voice; 02/03/2026Although usually offered in larger, comprehensive cancer centers, IO is expanding as new discoveries and applications emerge. Many oncology nurses could come in contact with […]
Trajectoires de soins
- Return to work for health professionals with breast cancer as health recipients: A systematized reviewon 16 mars 2026
Work. 2026 Feb 16:10519815251410109. doi: 10.1177/10519815251410109. Online ahead of print.ABSTRACTBackgroundHealth professionals are at increased breast cancer(BC) risk. Occupational factors are […]
Performance et indicateurs
- Educational intervention in advanced practice nursing for managing symptoms, toxicities, and quality of life in patients with lung canceron 16 février 2026
Enferm Clin (Engl Ed). 2026 Feb 12:502402. doi: 10.1016/j.enfcle.2026.502402. Online ahead of print.ABSTRACTOBJECTIVE: To evaluate the effectiveness of a proactive educational telephone intervention, […]
Amélioration de la qualité et meilleures pratiques
- Patient Advocate-Trainee Engagement in Oncology Education: Insights from a Short Pilot Surveyon 16 janvier 2026
J Cancer Educ. 2026 Jan 16. doi: 10.1007/s13187-025-02823-8. Online ahead of print.NO ABSTRACTPMID:41543684 | DOI:10.1007/s13187-025-02823-8
Innovation
- Evaluation of symptom-management medications for predicting short-term survival in advanced cancer patients with machine learningon 16 février 2026
Digit Health. 2026 Feb 3;12:20552076261419945. doi: 10.1177/20552076261419945. eCollection 2026 Jan-Dec.ABSTRACTOBJECTIVE: Estimating the diverse symptoms of patients with advanced cancer is helpful […]
Expériences des patients
Expériences des patients
- Navigating Parenthood in the Shadow of Cancer: A Scoping Review of Healthy Parents' Experiences.on 13 avril 2026
Seminars in Oncology Nursing; 04/01/2026This scoping review aimed to investigate the current knowledge regarding healthy parents' experiences of parenting children and young adults in families […]
Participation des patients
- Support through experience: The contribution of patient partners in oncologyon 16 janvier 2026
Soins. 2026 Jan-Feb;71(902):61-64. doi: 10.1016/j.soin.2025.11.015. Epub 2025 Dec 19.ABSTRACTThis article presents qualitative research, conducted in partnership with patient-partners-researchers, […]
Résultats rapportés par les patients
- A systematic review of patient and healthcare professional perceptions of the barriers and facilitators to embedding exercise in the adjuvant cancer treatment pathwayon 13 avril 2026
Support Care Cancer. 2026 Mar 18;34(4):342. doi: 10.1007/s00520-026-10553-w.ABSTRACTPURPOSE: Evidence suggests that physical activity and exercise interventions can mitigate cancer treatment side […]
Survivance
- Different exercise modalities and their effects on the inflammatory mediator repertoire in breast cancer survivors: A systematic review with Bayesian network meta-analysis and dose–response analysis.on 13 avril 2026
European Journal of Oncology Nursing; 04/01/2026This study compares the effects of different exercise modalities on inflammatory mediators in breast cancer survivors, evaluating aerobic exercise […]
Publications d'associations professionnelles
Canadian Association of Nurses in Oncology (CANO/ACIO)
- Therapeutic breakthroughs in oncology: Enhancing treatment and managementon 11 septembre 2025
Can Oncol Nurs J. 2025 Jul 1;35(4):590-605. doi: 10.5737/23688076354590. eCollection 2025.ABSTRACTRecent advancements in oncology have significantly transformed cancer treatment and care management, offering new hope to patients worldwide. This literature review examines key therapeutic breakthroughs, including targeted therapies, immunotherapies, personalized medicine, and innovative drug delivery systems. These cutting-edge interventions have enhanced patient outcomes, improving survival rates and quality of life, but they have also introduced complexities in managing emerging side effects, care coordination, and resource allocation. This review discusses the implications of these therapies on patient care, the ethical considerations they entail, the management of side effects, and the pivotal role of oncology nurses in administering and managing these treatments. By exploring the current landscape and future directions of oncology therapies, including areas such as cancer vaccines and precision medicine, this article provides a comprehensive understanding of how these innovations are shaping the future of cancer care.PMID:40873601 | PMC:PMC12379890 | DOI:10.5737/23688076354590
Oncology Nursing Society (ONS)
- ONS OCN® Certification Review Bundle Part 2: Oncology Nursing Practice Across the Cancer Continuum™on 13 avril 2026
ONS OCN® Certification Review Bundle Part 2: Oncology Nursing Practice Across the Cancer Continuum™ Kristina M. Gantner March 31, 2026 Products in Bundle ONS Scientific Basis of Cancer™ ONS Site-Specific Cancer Considerations™ ONS Psychosocial Dimensions of Cancer Care™ ONS Care Continuum™ ONS Oncology Professional Practice™ Teaser text The ONS OCN® Certification Review Bundle Part 2: Oncology Nursing Practice Across the Cancer Continuum™ provides essential, evidence‑based education aligned with the Oncology Nursing Certification Corporation (ONCC®) OCN® Test Content Outline to support certification preparation and strengthen real‑world oncology nursing practice. Member Price $290.00 Non-Member Price $240.00
American Society of Clinical Oncology (ASCO)
- Systemic Treatment of Thyroid Cancer: ASCO Guidelineon 13 avril 2026
J Clin Oncol. 2026 Apr 1:JCO2600235. doi: 10.1200/JCO-26-00235. Online ahead of print.ABSTRACTPURPOSE: To provide evidence-based recommendations on the use of systemic therapy in different types of thyroid cancers.METHODS: The American Society of Clinical Oncology convened a multidisciplinary Expert Panel to evaluate the evidence and formulate recommendations. The literature search included studies published between January 1, 2000, and November 5, 2025, and comprised systematic reviews, meta-analyses, randomized controlled trials, and observational studies. Outcomes of interest included overall survival, disease-free survival, and safety. Expert Panel members used available evidence and informal consensus to develop evidence-based guideline recommendations.RESULTS: A total of 66 publications were identified to inform the evidence base for this guideline.RECOMMENDATIONS: Evidence-based recommendations address the use of systemic therapy in patients with well-differentiated, differentiated high-grade or poorly differentiated, anaplastic, and medullary thyroid cancer.Additional information is available at www.asco.org/head-neck-cancer-guidelines.PMID:41921121 | DOI:10.1200/JCO-26-00235
National Comprehensive Cancer Network (NCCN)
- NCCN Guidelines® Insights: Distress Management, Version 1.2026on 13 avril 2026
J Natl Compr Canc Netw. 2026 Apr;24(4):e260018. doi: 10.6004/jnccn.2026.0018.ABSTRACTThese NCCN Guidelines for Distress Management discuss the identification and treatment of psychosocial problems in patients with cancer. They are intended to assist oncology teams to identify patients who require referral to psychosocial resources and to give oncology teams guidance on interventions for patients with significant distress. These guidelines also provide guidance for social workers, certified chaplains, and mental health professionals by describing treatments and interventions for various psychosocial problems as they relate to patients with cancer. These NCCN Guidelines Insights summarize the panel's most recent recommendations regarding standards of care for distress management in patients with cancer and implementation of these standards, including application of evidence-based care delivery models, such as the collaborative care model.PMID:41956112 | DOI:10.6004/jnccn.2026.0018
European Society for Medical Oncology (ESMO)
Pour obtenir les documents
L’accès au texte intégral des documents est restreint au personnel et aux médecins du CHUM en fonction des abonnements de la bibliothèque. Certains documents sont en accès libre sur le web.
Si vous êtes branchés sur le réseau CHUM :
Cliquer sur les liens fournis pour chaque référence pour vérifier la disponibilité du texte intégral.
Pour les articles provenant de PubMed, cliquer préalablement sur le lien suivant pour afficher la disponibilité du document.
Si vous êtes dans un autre établissement et que vous n’arrivez pas à accéder au texte intégral d’un article à partir du lien donné, vérifier auprès de la bibliothèque de votre institution en donnant la référence complète du document.
|
Avis de non-responsabilité
Le contenu des veilles informationnelles ou stratégiques (ci-après appelée « Veilles ») est mis à votre disposition à titre informatif pour un usage personnel exclusif. Tout usage commercial du contenu des Veilles est strictement interdit. Tous les éléments, articles, rapports ou toute autre source d’information figurant dans les Veilles, vous sont fournis « tels quels », sans garantie d’aucune sorte. Eu égard aux propos tenus dans les articles et les rapports sélectionnés pour les Veilles, le CHUM n’offre aucune garantie notamment d’exhaustivité, de fiabilité, d’actualité et d’exactitude.Le CHUM ne pourra en aucun cas être tenu responsable envers quiconque de tout dommage quel qu’il soit, même ceux directs, encouru notamment des suites de toute réclamation, action ou poursuite découlant, même directement, de l’utilisation de ces Veilles.
Les Veilles contiennent des liens vers des sites Web créés et mis à jour par des tierces parties. Ces liens sont fournis pour la commodité des utilisateurs seulement. Le CHUM n’endosse et ne garantit, ni explicitement ni implicitement, l’exactitude ou l’intégralité ni du contenu de ces hyperliens ni des opinions qui y sont exprimées. Le CHUM n’assume aucune responsabilité à l’égard de ces sites Web externes.
Le CHUM prend tous les moyens raisonnables afin de respecter les droits de propriété intellectuelle afférents au contenu des Veilles et aux modalités du prêt entre bibliothèques, émises par l’Université de Montréal. Le contenu des Veilles, incluant la manière dont il est présenté, sont notamment protégés par la Loi sur le droit d’auteur (L.R.C. (1985), ch. C-42). Le CHUM ne donne aucune garantie et ne fait aucune déclaration à l’effet que le contenu de ces veilles n’enfreint aucun droit d’une autre personne ou entité. Le téléchargement, la reproduction en un seul exemplaire ou le tirage sur papier des Veilles ne sont autorisés qu’à des fins de sauvegarde et pour un usage privé et non commercial. Tout téléchargement, reproduction, édition, diffusion sur Internet, utilisation à des fins commerciales ou publiques, distribution, publication sur un autre site ou sur quelque autre forme ainsi que toute autre utilisation est strictement interdite, à moins d’être faite dans le respect des règles de propriété intellectuelle applicables. |


